- Accenture's SWOT analysis: AI initiatives drive stock growth amid market challengesby Investing.com on May 27, 2025 at 11:44 am
- Should you buy a dip in BYD shares? JPMorgan weighs inby Investing.com on May 27, 2025 at 11:44 am
- FDA approves HADLIMA as interchangeable with Humiraby Investing.com on May 27, 2025 at 11:41 am
- Armlogi joins Russell Microcap Index, eyes investor growthby Investing.com on May 27, 2025 at 11:40 am
- SciSparc secures Japanese patent for pain relief comboby Investing.com on May 27, 2025 at 11:40 am
- Nexxen set for inclusion in Russell 3000 Indexby Investing.com on May 27, 2025 at 11:40 am
- Psyence BioMed advances Phase IIb psilocybin trial with new CRO partnershiby Investing.com on May 27, 2025 at 11:40 am
- Lexeo Therapeutics secures $80 million in private placementby Investing.com on May 27, 2025 at 11:40 am
- PENN Entertainment addresses shareholder concerns amid proxy battleby Investing.com on May 27, 2025 at 11:40 am
- Zimmer Biomet names new Group President for Americasby Investing.com on May 27, 2025 at 11:40 am
